Can anyone give me insight as to why this is going up? Is it only on the possibility of the drug returning to market or something else? TIA.
It's the potential of Tysabri of returning to the market by Fall, ELN's projection of break-even by early 2006 (without Tysabri), and theirexisting products.
Thanks for the reply. I'm considering a buy this morning.